1. Feng, Zhiping, Hom, Marisa E, Bearrood, Thomas E, Kuo, Calvin J, Chen, James K. 2022. Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1. In Nature chemical biology, 18, 1065-1075. doi:10.1038/s41589-022-01048-w. https://pubmed.ncbi.nlm.nih.gov/35788181/
2. Wang, Yewei, Popovic, Zeljka, Charkoftaki, Georgia, Chen, Ying, Vasiliou, Vasilis. 2023. Multi-omics profiling reveals cellular pathways and functions regulated by ALDH1B1 in colon cancer cells. In Chemico-biological interactions, 384, 110714. doi:10.1016/j.cbi.2023.110714. https://pubmed.ncbi.nlm.nih.gov/37716420/
3. Singh, Surendra, Arcaroli, John, Chen, Ying, Jimeno, Antonio, Vasiliou, Vasilis. 2015. ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways. In PloS one, 10, e0121648. doi:10.1371/journal.pone.0121648. https://pubmed.ncbi.nlm.nih.gov/25950950/
4. Zhao, Rong, Guo, Zizhen, Lu, Kaikai, Yin, Chunyan, Li, Dongmin. 2024. Hepatocyte-specific NR5A2 deficiency induces pyroptosis and exacerbates non-alcoholic steatohepatitis by downregulating ALDH1B1 expression. In Cell death & disease, 15, 770. doi:10.1038/s41419-024-07151-1. https://pubmed.ncbi.nlm.nih.gov/39438459/
5. Singh, Surendra, Arcaroli, John J, Orlicky, David J, Thompson, David C, Vasiliou, Vasilis. . Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma. In Pancreas, 45, 117-22. doi:10.1097/MPA.0000000000000542. https://pubmed.ncbi.nlm.nih.gov/26566217/